Roger G. H. Downer
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Chotchai Charoenngam | M | 61 |
Asian Institute of Technology
| 26 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Paul J. Schechter | M | 84 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 Jahre |
Eliot Lurier | M | 66 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 Jahre |
Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 Jahre |
Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 Jahre |
David Holtz | M | 58 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 Jahre |
Shao Hua Dai | M | 41 |
University of Limerick
| 1 Jahre |
Drajad Widiyanto | M | 60 |
Asian Institute of Technology
| 1 Jahre |
Paul Adams | M | - |
University of Limerick
| 1 Jahre |
John Shinnick | M | - |
University of Limerick
| 4 Jahre |
John Mescall | M | 43 |
University of Limerick
| 4 Jahre |
Setiawan Wangsaatmaja | M | 61 |
Asian Institute of Technology
| 2 Jahre |
Ross Nicholas | M | - |
University of Limerick
| 4 Jahre |
Kate Madden | F | - |
University of Limerick
| 6 Jahre |
Elaine Collins | F | - |
University of Limerick
| 4 Jahre |
Allan Mulrooney | M | - |
University of Limerick
| 4 Jahre |
Audrey Crummy | F | - |
University of Limerick
| 4 Jahre |
Shane Clifford | M | - |
University of Limerick
| 4 Jahre |
Alan Cuddihy | M | - |
University of Limerick
| 4 Jahre |
Aisling Meehan | F | - |
University of Limerick
| 4 Jahre |
Paul Kelly | M | - |
University of Limerick
| 4 Jahre |
Thongphet Chanthanivong | M | 62 |
Asian Institute of Technology
| 2 Jahre |
Keith James McKnight | M | - |
University of Limerick
| 4 Jahre |
Thang Minh Nguyen | M | 56 |
Asian Institute of Technology
| 1 Jahre |
Dwayne McNicholas | M | - |
University of Limerick
| 4 Jahre |
G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 Jahre |
Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 Jahre |
Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 Jahre |
Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 Jahre |
Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 Jahre |
David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 Jahre |
Scott H. Gillis | M | 71 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 8 Jahre |
Katherine J. Turner | M | 70 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 Jahre |
David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Paul Gleeson | M | - |
University of Limerick
| 4 Jahre |
Irakli Gilauri | M | 48 |
University of Limerick
| 4 Jahre |
Antoin Russell | M | - |
University of Limerick
| 2 Jahre |
Alan Dunne | M | - |
University of Limerick
| 2 Jahre |
Karl-Heinz Rinne | M | - |
University of Limerick
| 5 Jahre |
Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Martin Mellody | M | - |
University of Limerick
| 1 Jahre |
David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 Jahre |
Steve Mason | M | - |
University of Limerick
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Irland | 22 | 51,16% |
Vereinigte Staaten | 16 | 37,21% |
Thailand | 5 | 11,63% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Roger G. H. Downer
- Persönliches Netzwerk